GaryRHudesMD
Oncology • Philadelphia, PAMedical Oncologist, Philadelphia, Pennsylvania. Affiliated with multiple hospitals in the area, including Fox Chase Cancer Center and Temple University Hospital.
Are you Dr. Hudes?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 89 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
333 Cottman Ave
Fox Chase Cancer Center
Philadelphia, PA 19111Phone+1 215-728-6900Fax+1 215-728-3639
Summary
- Dr. Gary Hudes, MD is an oncologist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania. He is affiliated with Temple University Hospital and is a Medical Oncologist at Pennsylvania. Affiliated with multiple hospitals in the area.
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1983 - 1985
Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 1982 - 1983
Graduate HospitalResidency, Internal Medicine, 1979 - 1982
State University of New York Downstate Medical Center College of MedicineClass of 1979
Certifications & Licensure
PA State Medical License 1980 - 2016
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer Start of enrollment: 1999 Feb 04
- R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy Start of enrollment: 2000 Apr 01
- Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer Start of enrollment: 2001 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 347 citationsAxitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study.Olivier Rixe, Ronald M. Bukowski, M. Dror Michaelson, George Wilding, Gary R. Hudes
The Lancet. Oncology. 2007-11-01 - 2802 citationsTemsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.Gary R. Hudes, Michael A. Carducci, Piotr Tomczak, Janice P. Dutcher, Robert A. Figlin
The New England Journal of Medicine. 2007-05-31 - 145 citationsCutaneous metastases from genitourinary malignanciesThomas J. Mueller, Hong Wu, Richard E. Greenberg, Gary R. Hudes, Neil Topham
Urology. 2004-06-01
Professional Memberships
- Member
